Boots to begin prescribing medical cannabis in UK
Summary
Boots is launching SureLeaf, an online service that will assess and prescribe medical cannabis to eligible UK patients aged 25 and older. The service includes specialist consultations, independent clinical reviews and ongoing monitoring, alongside a research programme with the University of Nottingham focused on chronic pain.Key Facts
- Patients can apply online and have their suitability reviewed by a clinical team before a video consultation with a consultant.
- Boots says patients must have tried conventional treatments without success before receiving a prescription.
- Prescriptions will undergo review by a second independent consultant and a multidisciplinary clinical team.
- Boots will collaborate with the University of Nottingham to study patient outcomes, prescribing practices and experiences in chronic-pain treatment.
- Cannabis-derived medicines became legal to prescribe in the UK in 2018.
- On the NHS, medical cannabis is available only for certain rare forms of epilepsy, chemotherapy side effects and multiple sclerosis symptoms.
- A study by researchers in Australia and England found very little evidence that cannabis treats anxiety, anorexia nervosa, psychotic disorders, post-traumatic stress disorder or opioid use disorder.
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.